Clinical Trial

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-05; most recent amendment 2026-06-09.
Status change: Not Yet Recruiting → Recruiting 2026-02-24
Trial Details
NCT Number NCT07282587
Lead Sponsor Jazz Pharmaceuticals
Conditions Advanced Pheochromocytoma and Paraganglioma, PCPG
Enrollment 90 participants
Start Date 2026-01-02
Primary Completion 2028-12-15 (estimated)
Study Completion 2028-12-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-10